Ginkgo Bioworks Holdings, Inc.
DNA
$10.76
-$0.43-3.84%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.66% | 10.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.66% | 10.20% | |||
| Cost of Revenue | 23.03% | 25.20% | |||
| Gross Profit | -4.11% | 5.98% | |||
| SG&A Expenses | -11.75% | -5.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.22% | -1.22% | |||
| Operating Income | 29.68% | 6.54% | |||
| Income Before Tax | 33.33% | 15.75% | |||
| Income Tax Expenses | -421.59% | 127.08% | |||
| Earnings from Continuing Operations | 33.70% | 15.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.70% | 15.42% | |||
| EBIT | 29.68% | 6.54% | |||
| EBITDA | 36.55% | 7.48% | |||
| EPS Basic | 34.45% | 16.08% | |||
| Normalized Basic EPS | 31.58% | 5.35% | |||
| EPS Diluted | 34.52% | 15.92% | |||
| Normalized Diluted EPS | 31.58% | 5.35% | |||
| Average Basic Shares Outstanding | 1.14% | 0.79% | |||
| Average Diluted Shares Outstanding | 1.14% | 0.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||